Showing results (21-30 of 13,844) with videos related to
Sort By:
Pageof 1,385
American Heart Journal|February 15, 2011
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trialAdriano Caixeta, George D Dangas, Roxana Mehran, et al.American Heart Journal|February 15, 2011
Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: a subgroup analysis of the randomized, controlled CERTIFY studyUlrich Tebbe, Sebastian M Schellong, Sylvia Haas, et al.American Heart Journal|February 15, 2011
Common oral mucosal diseases, systemic inflammation, and cardiovascular diseases in a large cross-sectional US surveyStefano Fedele, Wael Sabbah, Nikos Donos, et al.American Heart Journal|August 1, 1990
PTCA following myocardial infarction: use of bailout fibrinolysis to improve resultsJ I Haft, J E Goldstein, M K Homoud, et al.American Heart Journal|December 21, 2010
Pseudoaneurysms of the mitral-aortic intervalvular fibrosa: survival without reoperationAmy Gin, Helen Hong, Andrew Rosenblatt, et al.American Heart Journal|December 21, 2010
Impact of intravascular ultrasound guidance on long-term clinical outcomes in patients treated with drug-eluting stent for bifurcation lesions: data from a Korean multicenter bifurcation registryJung-Sun Kim, Myeong-Ki Hong, Young-Guk Ko, et al.American Heart Journal|December 21, 2010
A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial designDavid Preiss, Naveed Sattar, John J McMurrayAmerican Heart Journal|May 1, 1990
Effects of glyburide on ischemia-induced changes in extracellular potassium and local myocardial activation: a potential new approach to the management of ischemia-induced malignant ventricular arrhythmiasS S Bekheit, M Restivo, M Boutjdir, et al.American Heart Journal|December 15, 2010
Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesionsLaura Mauri, Dean J Kereiakes, Sharon-Lise T Normand, et al.Pageof 1,385